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Histology of human tuhulo-interstitial nephritis associated with
antibodies to renal basement membranes. Twenty-seven patients
with diffuse "crescentic" glomerulonephritis (CSGN) were identi-
fied in 1,174 renal biopsies from nephritic patients. Patients were
assigned to three groups on the basis of the immunofluorescent
study of renal biopsy specimens and serologic findings. Group I
included eight patients with antibodies to glomerular (anti-GBM)
and tubular (anti-TBM) basement membranes; group II had eight
patients with only anti-GBM antibodies; and group III had eleven
patients with CSGN unassociated with antibodies to either GBM
or TBM. Patients with anti-GBMIanti-TBM antibodies (group I)
had severe tubulointerstitial (TI) nephritis, as characterized by the
infiltration of polymorphonuclear leukocytes and macrophages
along the TBM and peritubular vessels. In some patients, focal
proliferation of epithelial cells of proximal convoluted tubules
(PCT), gaps or extensive destruction of TBM, lesions in the walls
of small peritubular vessels, and interstitial giant cells were also
observed. Patients with anti-GBM antibodies (group II) had mild
to moderate interstitial cellular infiltration and mild tubular
changes. Five patients with CSGN not associated with antibodies
to renal basement membranes (group III) had mild to moderate
interstitial cellular infiltration and tubular changes. A sixth patient,
with Wegener's disease had severe granulomatous TI lesions. The
results of this study show that TI nephritis is most frequent and
severe when anti-TBM antibodies are demonstrable and suggest
that anti-TBM antibodies contribute to the development of TI
lesions.
Histologie de Ia néphrite tubulo-interstitielle humaine associée a
Ia presence d'anticorps anti-membrane hasale. Vingt-sept malades
atteints de glomdrulondphrite diffuse avec des croissants (CSGN)
ont Cté identifies a partir de 1174 biopsies rénales rflalisées chez
des malades atteints de néphrite. Les malades ont été répartis en
trois groupes sur Ia base de l'étude en immunofluorescence des
biopsies rénales et des constatations sdrologiques. Le groupe I
comprend huit malades qui ont des anticorps anti-membrane ba-
sale glomérulaire (anti-GBM) et tubulaire (anti-TBM), le groupe II
comprend huit malades qui n'ont que l'anti-GBM et le groupe III
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comprend onze malades atteints de CSGN mais qui n'ont ni les
anti-GBM ni les anti-TBM. Les malades qui ont les deux anticorps
(groupe 1) ont une néphropathie tubulointerstitielle sévCre carac-
térisfle par des infiltrats leucocytaires et macrophagiques le long
des membranes basales tubulaires et des vaisseaux péri-tubulaires.
Chez quelques malades, Ia proliferation focale des cellules épithC-
hales du tube contournC proximal (PCT), des solutions de contin-
uité ou des destructions étendues de la basale tubulaire, des
lesions des parois des valsseaux péritubulaires de petit calibre et
des cellules interstitielles géantes sont aussi observées. Les ma-
lades qui ont des anticorps anti-GBM (groupe II) ont une infiltra-
tion interstitielle et des modifications tubulaires modCrées. Cinq
malades atteints de CSGN sans anticorps anti-membranes basales
(groupe III) ont une infiltration interstitielle et des modifications
tubulalres moddrdes. Un sixitme malade atteint de maladie de
Wegener a des lesions tubulo-interstitielles granulomateuses se-
véres. Le résultat de cette étude démontre que la néphropathie
tubulo-intèrstitielle est plus frCquente et plus sévCre quand les
anticorps anti-TBM sont mis en evidence et suggCrent que les
anticorps anti-TBM contribuent au développement des lesions
tubulo-interstitielles.
Evidence, derived from both experimental models
and human diseases, suggests that tubulo-interstitial
(TI) nephritis occasionally can be produced by anti-
body reacting with tubular basement membrane
(TBM) [1, 2]. Anti-TBM nephritis in guinea pigs [31
or Brown Norway rats [4, 5] is characterized by
distinctive immunopathologic features which in-
clude: 1) linear deposits of IgG and C3 in TBM; 2)
accumulation of inflammatory cells along TBM; 3)
extensive destruction with formation of "gaps,"
thickening or "splitting" of TBM, and 4) formation
of giant cells in the interstitium. In man, anti-TBM
antibodies are most frequently found in association
with anti-glomerular basement membrane (GBM)
disease. This disease manifests itself clinically either
as glomerulonephritis alone, or as Goodpasture's
syndrome (GS) [6]. There is little information as to
whether or not anti-TBM antibodies are associated
with distinctive histologic changes. In order to assess
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the importance and the specific role of anti-TBM
antibody in human renal diseases, we have studied
renal tissue from patients with "crescentic" glomer-
ulonephritis (CSGN) and have compared the TI le-
sions of patients with anti-GBMJanti-TBM nephritis
with those found in patients with anti-GBM glomeru-
lonephritis and patients with CSGN not mediated by
antibody to renal basement membranes.
Methods
Patients. Twenty-seven patients with CSGN in-
volving 60 to 100% of the glomeruli were selected
from renal biopsies from 1,174 nephritic patients.
Patients were divided into three groups according to
immunofluorescent findings in renal biopsies and sero-
logic studies. Group I comprised eight patients with
CSGN and antibodies to GBM and TBM. Group II
included eight patients with CSGN and antibodies to
GBM. Group III included eleven patients with
CSGN and no demonstrable antibodies to renal base-
ment membranes. Twenty-two patients were admit-
ted and studied in hospitals affiliated with the Medi-
cal School of the State University of New York at
Buffalo. Patient 14 was studied in 1966 in the labora-
tory of Dr. B. C. Seegal, Department of Microbiol-
ogy, Columbia University, New York. Tissues, clini-
cal, and laboratory findings from patient 6 were
kindly provided by Dr. G. Abouna, Department of
Surgery, University of Calgary. Patients 17, 19, and
23 were under the care of Dr. G. Andres in the Renal
Unit of the Clinica Medica, University of Rome.
Tissue processing for light and electron micros-
copy. Kidney specimens were obtained by biopsy, or
were collected from kidneys removed either prior to
renal transplantation or at autopsy. Tissues were
divided into three parts. One part was fixed in 10%
buffered formalin and embedded in paraffin. Serial
sections of 2 to 3 were cut and stained with hema-
toxylin and eosin, periodic-acid Schiff (PAS) reagent
and silver-methenamine for light microscopic exami-
nation. A second part was fixed in 2% paraformalde-
hyde-glutaraldehyde solution, post-fixed in osmium
tetroxide, and embedded in Epon 812. Sections 0.5
in thickness were stained with toluidine blue and
examined by light microscopy. Thin sections were
stained with lead hydroxide, uranyl acetate, or both
and were examined with a electron microscope (Sie-
mens 101). The third part was "snap frozen" in
liquid nitrogen, mounted in O.T.C., and sectioned in
a cryostat at 4-.t thickness for immunofluorescence
microscopy. The lesions observed by light micros-
copy were graded by semiquantitative analysis [7].
Immunohistological and serological techniques.
Direct immunofluorescence on tissue sections was
performed as previously described [8]. Sera and re-
nal or lung eluates were tested by indirect immuno-
fluorescence for the presence of anti-renal basement
membrane antibodies [9]. Serum samples of three
patients were tested by a radioimmunoassay for anti-
GBM antibodies [10]. For elution of antibodies
bound in vivo to kidney or lung, the tissues were
minced, washed free of blood, and homogenized in
0.15 M sodium chloride. The homogenate was centri-
fuged at x 1100 g for 15 mm, and the sediment was
washed repeatedly with 0.15 M sodium chloride until
the supernatant was clear. To the washed sediment,
0.02 M citrate buffer (pH, 3.2) was added to make a
10% suspension. After incubation at 37° C for two
hours, the suspension was centrifuged at x27,000 g
for 30 mill. The supernatant was adjusted to a pH of
7.3 with 1.0 N sodium hydroxide and then was con-
centrated by ultrafiltration [11].
Individual immunofluore scent findings were
graded according to intensity and extent from 0 to
3+.
Results
Clinical presentation and course. The most rele-
vant clinical and laboratory data of patients with anti-
GBMIanti-TBM disease (group I) and anti-GBM
disease (group II) are summarized in Table 1. No
significant differences were observed between the
two groups. Anti-renal basement membrane disease
predominated in adult males (13 males and 3 females)
with a median age of onset of 50 yr. Four patients
(25%) had an antecedent history of rheumatoid ar-
thritis. Antecedent upper respiratory tract infections
(presumably viral) were also frequent (44%). Two
patients (13%) had had a bladder or endometrial
carcinoma two to three years before developing ne-
phritis. One patient had been vasectomized, and two
years later, had developed idiopathic membranous
nephropathy. Pulmonary symptoms were found in
50% of the patients (three in group I and five in group
II). Six patients (38%) had hemoptysis and pulmo-
nary infiltrates, and only three (19%) had pulmonary
infiltrates. Rapidly progressive renal failure occurred
in ten patients (63%) (five in group I and five in group
II). Renal glucosuria was present in four patients
(25%; two in group I and two in group II). The initial
therapy consisted of the administration of cortico-
steroids (five patients in group I and five in group II),
anticoagulation (two patients in group I and one in
group II), and dialysis (all patients in group I and four
in group II). Bilateral nephrectomy to control pulmo-
nary symptoms was performed in only one patient
(patient 9, Table 1). Ten patients (63%) died (four in
group I and six in group II). Six are alive: two with
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3 65/M Rheumatoid 0.5B
arthritis
21/M URTI lB
7 56/F Rheumatoid 15A
arthritis
8 71/F Endometrial IIB
carcinoma
11 66/M Rheumatoid ar-
thritis; URTI;
bladder
carcinoma
12 60/M Hypertension
13 33/M Drug addiction 0.5B
16 49/M Vasectomy; 1A
membranous
nephropathy
Group It: Patients with anti-GBM nephritis
l.5B Dialysis yes
lB 4.3
yes Died after 15 mo. (sepsis;
respiratory insufficiency)
no no Alive with functioning renal
allograft, 52 mo. after
diagnosis
no no Alive 12 months after diagno-
sis—patient is in a chronic
hemodialysis program
no yes Died after 3 weeks (sepsis)
no yes Died after 6 weeks (myocar-
dial infarction)
no no Alive with functioning renal
allograft 24 mo. after
diagnosis
yes no Died after 15 mo. (cerebro-
vascular accident; bacterial
endocarditis)
no no Alive 18 mo. after diagno-
sis—patient is in a chronic
hemodialysis program
yes Died after 5 mo. (respiratory
insufficiency)
no yes Died after 15 mo. (respiratory
insufficiency; cerebrovas-
cular accident)
yes yes Died after 4 mo. (uremia)
no no Alive 24 mo. after diagno-
sis—creatinine, 2.0 mg/lOU
ml
no yes Alive 24 mo. after diagno-
sis—creatinine, 4.5 mg/l00
ml
no yes Died after 3 weeks (uremia)
no no Died after 15 mo. (cause un-
known)—patient was in a
chronic hernodialysis
program
no no Died after I mo. (cause
unknown)
biopsy; N, nephrectomy, prior to
Table 1. Clinical and laboratory dataa
Kidney function
at time of renal
Time between I st tissue sampling Hemoptysis
signs of nephritis creatinine in and/or
Patient Antecedent and renal tissue mg/IOU ml or Renal pulmonary
no. Age/sex illness sampling, months dialysis glucosuria infiltrates Course
1 2l/M
2 50/M
URTI
URTI
Group 1: Patients with ant i-GBM/anti-TBM nephritis
0.5B; ISN Dialysis yes
7B
4
5
6
77/M URTI
58/M URTI
0.5B; 0.7A
lB
Dialysis
Dialysis
Dialysis
Dialysis
11
Dialysis
Dialysis
9 57/M
10 56/M
Rheumatoid
arthritis
2B
0.5B
14 29/M URT1
15 39/F —
4.9
2.3
3.6
13
4.6
18
0.7A
3B; 15A
a Abbreviations used are: URTI, upper respiratory tract infection, preceding the onset of nephritis; B,
renal transplantation; A, autopsy; mo., months.
chronic uremia, not necessitating dialysis; two
treated with chronic hemodialysis; and two with
functioning renal allografts.
Immunopathology. Kidney specimens were ob-
tained within two months after the first signs of
nephritis in five patients of group I and six of group II
(Table 1). In the remaining patients, kidney tissue
samples were collected 3 to 15 months after the onset
of the disease. The results of the immunopathologic
studies are summarized in Table 2.
Group 1. All patients had linear deposits of IgG in
GBM and TBM (Fig. 1). The intensity and extent of
immunofluorescent staining was higher in GBM and
in the basement membrane of Bowman's capsule
than it was in TBM, with the exception of that from
patient 5. Tubular deposits were focal or diffuse,
usually circumferential, and mainly localized in the
basement membranes of the proximal convoluted
tubules (PCT). Deposits of C3 in GBM were granular
in three of six patients. In TBM, the deposits of C3
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Fig. 1. Patient]: Linear deposits oflgG in GBM and TBM ( x250).
were slight and linear in four patients, and granular
and linear in one. Fibrinogen was localized mainly in
epithelial crescents and, to a lesser extent, in TBM.
In patients I and 4 with GS, linear deposits of IgG
were also present in lung alveolar basement mem-
branes (ABM). Lung tissue of other patients was not
examined.
Five of the seven patients tested (patients 2—4, 6,
and 8) had circulating antibodies to GBM detectable
by indirect immunofluorescence. In patient 1, circu-
lating anti-GBM antibodies were detectable only by
radioimmunoassay. Four kidneys were available for
elution. Sera and eluates usually reacted with GBM
of normal human kidney. All four eluates contained
antibodies reacting with GBM; only the eluates of
patients 1 and 5 reacted with both GBM and TBM.
The reactivity of the renal eluates with ABM was not
systematically tested.
Table 2. Immunopathologic studies*
Light microscopy Direct immunofluorescence Indirect immunofluorescence
Serum Renal eluate
GBM TBM GBM TBMPatientno.
TBM
changes
Interstitial
cellular
infiltration
GBM TBM and BC
IgG C3 Fibrin(ogen) IgG C3 Fibrin(ogen)
Group I: Patients with anti-GBM/anti-TBM nephritis
1 ++ +++ +++L +L
2 +++ +++L
3 +++ +++ +++L
4 +++ +++ +++L
5 +++ +++
6 ++ ++ +++L
7 ++ ++ +++L
8 + ++ +++L
9 + ++ +++L
10 + ++ +++L
11 + + +++L
12 + ++ ++L
13 + ++ ++L
14 0 ++ +++L
15 + ++ +++L
16 + + +++L ++
÷
+, C
+++, C
C
++, C
+
NT
II: Patients
+++, C
+
0
0
+
NT
0
+ +L
+G
++G
+L
NT
Group
+, G
L
+, G
G
++, G
+, G
+, G
G
++
+++
+
NT
+
0
+*
0* 0 ++
0 NT
++ NT
0 +++
NT ++
0 NT
0 ++
0 NT
0 +L +L
+L +L,G
++L 0
++L
+++L +,L
+++L 0
++L +,L
++L NT
with anti-GBM nephritis
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
+
NT
NT
0
++
NT
0
NT
+
++, C
0
+, C
+, C
+C
0 0* 0 NT
0 0 0 NT
0 0 0 NT
0 0 0 NT
0 0 0 NT
0 0 0 +++
0 0 0 0
0 0 0 ++
NT
NT
NT
NT
NT
0
0
0
Group II]: Patients with "crescentic" glomerulonephritis not associated with anti-GBMIanti-TBM antibodies
Diagnosis
17 0 0 +G +, G 0 0 Schonlein-Henoch purpura
18 + + +G +, G 0 0 0 SchOnlein-Henoch purpura
19 0 + + + + + G +, G G +, G 0 Systemic lupus erythematosus
20 + ++ ++G ++, G + +, G 0 0 Systemic lupus eiythematosus
21 + + + + +G +, G + + +, G + +, 0 0 Allergic angitis
22 0 0 + El + +, El + 0 0 0 Allergic angitis
23 0 0 ++G +, G 0 0 0 0 LJnclassffied immune complex
nephritis
24 ++ ++ +++G ++, G + 0 0 0 Unclassified immune complex
nephritis
25 0 0 +G +, G 0 0 0 0 Unclassified immune complex
nephritis
26 0 0 0 G + + 0 0 0 Hemolytic-uremic syndrome
27 +++ +++ +G +, G + 0 0 0 Wegener's granulomatosis
used are: GBM, glomerular basement membrane; TBM, tubular basement membrane; BC, Bowmans capsule; L, linear;
El, granular; C, fibrin(ogen) localized in crescents; NT, not tested; ', positive by radioimmunoassay. The TBM changes and the interstitial
infiltration were graded as follows [7]: 0, absent; minimal; +, mild; + +, moderate; + + +, severe. The immunofluorescence findings were
graded according to intensity and extent, from 0 to + ++.
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Fig. 2. Patient 2: Increased torruosily and epithelial degeneration in a PCT (silver-methenamine: x200).
Fig. 3. Patient 3: The basement membranes of'two PCT are thinned or have disappeared (arrows). Damage of epitheliai cell cytoplasm is
also visible (silver-methenamine; x200).
Fig. 4. Patient 3:Inflammatory cells (arrows) are present between the epithelial cells of a tubule (H&E: 3OO). The inset shows a mitotic cell
(arrow) adjacent to a tubule (H&E: x300).
Light microscopy examination of renal tissue sec-
tions showed crescents occluding Bowman's space
in 60 to 100% of the glomeruli. "Pseudotubules" [121
occasionally surrounded the collapsed and com-
pressed glomerular tufts. The exuberant proliferation
of epithelial cells was associated with focal disrup-
tion of Bowman's capsule, particularly at the vascu-
lar pole. In addition to epithelial cells, some cres-
cents contained few, and rarely many, large cells
with a single pale nucleus, resembling epithelioid
cells. These cells were clustered around fragments of
basement membrane. In patients 1, 4, and 5, the
presence of the epithelioid cells was associated with
that of giant cells.
The PCT showed focal epithelial hyperplasia, in-
creased tortuosity, and dilatations (Fig. 2). Focal
epithelial cell proliferation ("tubular increscences")
[131, leading to enlargement and distortion of the
tubular segment contiguous to the pseudotubules,
was seen in patients 1, 2, 5, and 8. Pseudotubules
were present only in a few glomeruli; proliferation of
epithelial cells was seen in only a few PCT and not in
all renal sections. The results of the study of serial
sections suggested occasional continuity between
the proliferated tubular cells of PCT and those of
Bowman's capsule. In tissues stained with silver-
methenamine, the TBM was split, distorted, or fo-
cally damaged with areas of thickening, thinning,
gaps, or complete disappearance (Figs. 2 and 3). As a
consequence of TBM breaks, the lumina of some
tubules appeared to communicate with the renal in-
terstitium. Leukocytes were found between tubular
epithelial cells (Fig. 4). The tubular lumina contained
cellular debris, macrophages, red blood cells, and
proteinaceous material (Fig. 3). Extensive tubular
atrophy or tubular loss associated with interstitial
fibrosis was frequent in patients with advanced
disease.
Moderate to severe interstitial infiltration of lym-
phocytes, monocytes, and a minor number of poly-
morphonuclear leukocytes and plasma cells was seen
in the interstitium, mainly around the PCT. In pa-
tients 1, 4, and 5, a few giant cells were also present
in the interstitium (Figs. 5 and 6) and around Bow-
man's capsule (patient 4).
Patients 1, 4, and 6 had cellular infiltrates around
the walls of juxtamedullary veins (Fig. 7). Patient 6
had a variable degree of hyperplasia of the smooth
muscle cells in the walls of the veins. In patients 1
and 4, round structures were present in the juxta-
medullary part of the kidneys. These structures mea-
sured 1 to 5 p in diameter. In patient I, they were
larger (5 /L to 1 mm) and visible by macroscopic
examination (Fig. 8). Microscopic examination
showed proliferation of cells with vesicular nuclei
and certain features of fibroblasts or features inter-
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Fig. 5. Patient 5: Interstitial cellular infiltration. The arrows
indicate giant cells. (H&E; x200).
mediate between those of fibroblasts and smooth
muscle cells (Fig. 9 and inset). Strands of basement
membrane-like material were present between the
cells. Serial tissue sections showed that these struc-
tures were connected with the walls of juxtamedul-
lary veins (Fig. 10) and had originated from the
proliferation of adventitial cells. Recanalization, with
formation of new endothelium, was occasionally ob-
served in the central area of these structures.
By electronmicroscopy, the lumina of peritubular
vessels were dilated and contained fibrin, degranu-
lated platelets, and polymorphonuclear leukocytes.
The most severe lesions were seen in the venules and
Fig. 6. Higher magnification of two giant cells seen in Fig. 5
(H&E; x500).
Fig. 7. Patient 4: Cellular infiltration along the walls of a vein (v).
a indicates the lumen of an arteriole. (H&E; x200.)
Fig. 8. Patient 1: Cross section of a kidney showing cortex and
medulla. The arrows indicate round juxta-medullary structures of
various sizes. (H&E; xl.8.)
in the veins. The basement membranes were wrin-
kled and surrounded by cytoplasmic projections of
macrophages, and the endothelium was disrupted or
missing (Fig. 11). In active stages of disease, poly-
morpohonuclear leukocytes, lymphocytes, and mon-
ocytes were present in the interstitium, sometimes in
contact with the interstitial (Fig. 12) or epithelial side
of the TBM. The TBM was either morphologically
normal or slightly thickened. In later stages, the cells
around the TBM were mainly macrophages (Fig. 13).
In some areas, the TBM was thinned, disrupted (Fig.
14), or missing; in other areas, it was thickened, and
"spikes" and layers of newly formed basement
Fig. 9. Patient]: Juxta-medullary structure fbrmed by cells con-
nected with silver-positive fragments of basement membrane. The
arrow head points to an arteriole. (Silver methenamine; x 300.)
The inset illustrates some morphologic aspects of the proliferated
cells indicated by the arrow in Fig. 9. (Silver-methenamine; x500.)
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Fig. 10. Patient]: One jnxta-medullary structore connected with the wall of a vein (v). a indicates arteriole. (Silver-methenamine; x200.)
Fig. 11. Patient 3: Necrosis of a small peritubolar vessel. Maerophages (M) extend their psendopodia (p) around the basement membrane
(bm) which is undulated and devoided of endothelial cover. Part of a macrophage (x) is visible within the lumen (c) of the vessel. (x 4,000.)
Fig. 12. Patient 2: Two polymorphonuclear leukocytes (p) are in contact with the basement membrane (bm) of a PCT. The epithelial cells
show numerous vacuoles, eytosomes, and loss of brush border. (x5,000.)
t
Sm
10
•
"I
•-: A
'1
Anti-renal basement membrane nephritis 487
Fig. 13. Patient 3: A macrophage (M) is in contact with a TBM (asterisk). The lumen of the tubule contains fibnn (I) and proteinaceous
material. (x6,000.)
membrane were seen on the epithelial side. Lympho-
cytes, monocyte s, and macrophages penetrated
through gaps of the basement membrane and were
found between tubular epithelial cells (Fig. 14). The
epithelial cells of PCT showed a variety of degenera-
tive lesions, characterized by fragmentation or loss
of brush border, homogenization of the apical por-
tion with disappearance of cell organelles, and de-
tachment of apical cytoplasmic fragments into the
lumina. Large vacuoles, derived from dilated phago-
somes and lysosomes, were present in the central
and basal part of the cells. The infoldings of the basal
plasma membrane were replaced by a continuous
sheet of cytoplasm with bundles of electron-dense
myofibrils. In some PCT, the loss of the epithelium
and the gaps in the basement membrane allowed
direct communication between tubular lumina and
interstitium. Less severe and more focal changes
were observed in distal convoluted tubules and in
Henle's loops.
Group II. The eight patients with only anti-GBM
antibody had linear deposits of IgG in the GBM.
Glomerular deposits of C3 were mainly granular.
Patient 16, described in a previous publication [11],
had biopsy-proven membranous nephropathy with
granular, ribbon-like deposits of IgG in GBM and
before CSGN and fatal renal failure developed. Pa-
tient 14, had severe pulmonary hemorrhages and
linear deposits of IgG and C3 in ABM. The immuno-
fluorescence of the lung of another patient with GS
(patient 9) proved to be negative. Lung tissue of the
remaining patients was not examined.
Antibodies to GBM were not detectable by indi-
rect immunofluorescence in the sera of the seven
patients tested (patients 9—11 and 13—16). The serum
of patient 9, however, was positive for anti-GBM
antibodies by radioimmunoassay. Three kidneys (pa-
tients 14—16) were available for elution. Two eluates
(patients 14 and 16) reacted strongly with GBM. In
the eluate of the third kidney, which was sclerotic
and showed only focal deposits of complement by
direct immunofluorescence, anti-GBM antibodies
could not be shown. Antibodies to TBM were detect-
able neither in sera nor in renal eluates. All patients
had glomerular lesions comparable in severity to
those of patients in group I. The interstitial infiltra-
tion of lymphocytes, monocytes, and macrophages
was less severe than that in patients of group I.
Patient 16 had no interstitial mononuclear cell infil-
tration in the biopsy which showed only membra-
nous nephropathy [11]; moderate interstitial nephri-
tis was demonstrable when the anti-GBM gb-
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merulonephritis was superimposed. Then the TBM
changes characterized by focal thickening and "split-
ting" were neither as frequent nor as pronounced as
in patients of group I. Proliferation of tubular epithe-
hal cells, interstitial giant cells, and proliferation of
the advential cells of the walls of juxta-medullary
veins were not observed. In patient 9, an occasional
giant cell was seen in Bowman's space.
Group III. This group included 11 patients with
CSGN not associated with anti-basement membrane
antibodies. Granular deposits of IgG and C3 were
found in glomeruli of 10 and in TBM of three pa-
tients, two with SLE and one with allergic angitis.
Mild to moderate focal interstitial cellular infiltration
was present in five, and moderate alterations of TBM
was present in two patients. Only patient 27 (Wege-
ner' s disease) had severe interstitial granulomatous
lesions and tubular damage. Of the three patients
with granular immune deposits in TBM (patients 19—
21) only one (patient 21) had mild interstitial cellular
infiltration. Using electron microscopy, we saw a
few dense deposits along the TBM in patients 19 and
20, who had SLE nephritis. Epithelial proliferation in
PCT, giant cells in the interstitium or Bowman's
space and proliferation of adventitial cells in the
walls of juxta-medullary veins were not observed.
Discussion
The nephritis induced by antibody to GBM repre-
sents a well established dinico-pathological entity.
The analysis of our series of patients with anti-GBM
nephritis confirms the preponderance in adult males
[6] and shows that 25% of patients had an antecedent
history of rheumatoid arthritis andlor respiratory
tract infection (44%). There was no apparent differ-
ence between the course and the outcome of anti-
GBMJanti-TBM disease and that of anti-GBM dis-
ease. This observation may suggest that anti-TBM
antibody has no primary importance in the clinical
evolution. This hypothesis, however, cannot be ade-
quately tested in our patients because their number is
too small and the treatment was not the same in all
patients.
According to Wilson and Dixon, anti-GBM anti-
bodies are responsible for about five percent of im-
munologically mediated human nephritides, and
Fig. 14. Patient 2: Degenerative lesions in the epithelium (ep) of a PCT. Two polymorphonuclear leukocytes (p) are between the epithelial
cells. The basement membrane (bm) is thickened and interrupted (arrow). A lymphocyte (L) is present in a gap of the basement membrane.
Other lymphocytes (1) are in the interstitium. (x7,000.)
_j eA.JcT .!.!!4Tt. p
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anti-TBM antibodies are found in about 70% of such
patients [6]. In our series of 1,174 nephritic patients,
the frequency of anti-GBM nephritis was 1.36%.
Eight of 16 patients with anti-GBM nephritis had also
antibodies to TBM (0.68% of the total number of
patients examined). In only one of these eight pa-
tients did the anti-TBM disease appear to dominate
the anti-GBM disease (0.08%). These figures suggest
that the renal disease mediated by antibody to GBM
is uncommon and that the disease associated with
anti-TBM antibodies only is rare indeed. The lower
frequency of anti-GBM nephritis in our series of
nephritic patients, as compared to the series of Wil-
son and Dixon [61, is probably due to a more ran-
domized group of patients studied with less sensitive
serological techniques. Moreover, cases with anti-
TBM disease associated with renal transplantation
[14, 15] or with the administration of antibiotics of
the penicillin group [16—18] were excluded.
Antibodies to GBM were more frequently detecta-
ble by indirect immunofluorescence in the sera of
patients with anti-GBM/anti-TBM nephritis (5/7)
than in the sera of those with anti-GBM nephritis
alone (0/8). These findings might indicate that bind-
ing of antibody to TBM occurred because a larger
amount of antibodies were present in the circulation
of patients with anti-GBMJanti-TBM nephritis. How-
ever, the observation that patient 5 had predomi-
nantly anti-TBM nephritis and that the renal eluates
of patients 1 and 5 reacted in vitro with TBM favors
the interpretation that anti-TBM antibodies are di-
rected against specific TBM determinants [19].
Comparative studies performed with sera and re-
nal eluates in patients 1, 4, 7, 14, and 16 confirmed
that antibodies to renal basement membranes are
more concentrated in eluates than in sera [10]. Re-
suits obtained in patients 1 and 9 confirmed that the
radioimmunoassay for anti-GBM antibody is more
sensitive than the indirect immunofluorescence test
[10].
In patients with anti-GBMJanti-TBM antibody
(group I), interstitiai cellular infiltration and TBM
changes were more severe than they were in patients
of groups II and III; in addition, some patients of
group I had focal proliferative lesions of epithelial
cells in PCT and of giant cells in the interstitium. The
results of the study of serial tissue sections suggested
that the diffuse proliferative lesions induced in gb-
meruli by anti-GBM antibody may occasionally have
its counterpart in PCT. Epithelial cell proliferation in
Bowman's space appeared to be continuous with
epithelial cell proliferation in PCT. Pseudotubules,
produced by the duplication of Bowman's capsule
[12], were associated with an increased tortuosity of
the contiguous PCT. Alterations of GBM and TBM
were morphologically similar: in GBM, there were
discrete or extensive perforations, associated with
local accumulation of inflammatory cells; in TBM of
PCT, there were gaps thinning or thickening with
local accumulation of inflammatory cells. These lat-
ter lesions are reminiscent of tubular changes elicited
in Brown Norway rats by anti-TBM antibody [4].
Proliferation of the epithelial cells of PCT ("tubu-
lar increscences") was described in 1959 by Garcia-
Caceres in patients with rapidly progressive glomer-
ulonephritis [13] ("subacute glomerulonephritis" of
Voihard and Fahr [20]). More recently, proliferation
of tubular epithelial cells was observed in patients
[21, 221 and in sheep [231 with anti-basement mem-
brane nephritis. The proliferation of epithelial cells in
PCT is not a prominent feature of anti-TBM nephritis
in either guinea pigs [3] or in Brown Norway rats [4].
Therefore, the morphologic similarities between
ovine [23] and human anti-renal basement mem-
brane nephritides could result from an enhanced epi-
thelial response in these species to nephrotoxic
injury.
The formation of crescents has been ascribed to
the deposition of fibrinogen products in Bowman's
space [24]. This interpretation is consistent with our
observation that fibrinogen deposits are frequent (9/
16) in Bowman's space in patients with anti-GBM
antibody. Nevertheless, it is attractive to speculate
that antibodies to renal basement membranes may be
responsible for the simultaneous proliferation of epi-
thelial cells in glomeruli and in PCT, because the
epithelial cells of the nephron share common compo-
nents with glomerular and tubular basement mem-
branes [25—29].
Another characteristic of anti-GBMlanti-TBM ne-
phritis is the severity of interstitial cellular infiltration
with the occasional presence of epithelioid and giant
cells, similar to those seen in the crescents of pa-
tients with anti-GBM glomerulonephritis [21, 30—35]
or in the interstitium of a patient with anti-TBM
nephritis [18]. Giant cells were not attached to the
TBM of PCT and were thus more similar to those
found in Brown Norway rats [4] than to the large,
peritubular, giant cells of guinea pigs [3] with anti-
TBM nephritis. In viva studies have shown that giant
cells may occur in diseases induced by antibody-
mediated [3—5, 36] or by cell-mediated [37—40]
hypersensitivity. In patients with anti-GBM glomer-
ulonephritis, both antibody- and cell-mediated hy-
persensitivity may have a pathogenetic role, since
cell-mediated reactivity to GBM frequently develops
during the course of the disease [41, 42].
Two patients of group I had a variable degree of
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proliferation of adventitial cells in juxtamedullary
veins, with the occasional formation of nodular
structures visible by macroscopic examination of re-
nal tissue sections. A comparable proliferation of
adventitial cells of the veins or arterioles has been
observed in the kidneys of a few patients on chronic
dialysis [43] or in renal allografts of patients with TI
nephritis (SLAV1N ER, personal communication). Al-
though exudative or necrotizing vasculitis involving
renal and extrarenal small arteries has been de-
scribed in two patients with anti-GBM nephritis [301,
the vascular changes were not comparable to those
found in our patients. The pathogenesis and the sig-
nificance of these vascular lesions are unknown (see
Addendum).
Patients with anti-GBM glomerulonephritis (group
II) and patients with CSGN not associated with anti-
bodies to renal basement membranes (group III) also
could show interstitial nephritis and tubular damage,
but the TI lesions were not as severe or as extensive
as they were in patients with anti-GBM-anti-TBM
nephritis (with the only exception of the patient with
Wegener' s granulomatosis). Furthermore, wide-
spread destruction of TBM, tubular epithelial cell
proliferation and degeneration, and interstitial giant
cells were not observed.
In patients with anti-renal basement membrane
nephritis, it is difficult to evaluate the pathogenetic
role of anti-TBM antibody since the glomerular dis-
ease is often severe enough to cause marked impair-
ment of renal function. The observations that many
such patients have severe inflammatory TI changes
[1, 2, 6, 30, 44] and the reports that anti-TBM nephri-
tis can occur without apparent association with anti-
GBM antibody [14—18, 45—50] indicate that the anti-
TBM antibodies are of importance. The results of
this study strengthen this interpretation and suggest
that antibody to TBM may occasionally be associ-
ated with TI changes reminiscent of the experimental
anti-TBM nephritis of guinea pigs [3] or Brown Nor-
way rats [4, 51.
Addendum. L. McManus et al recently described nodule
formation in intrarenal vessels of end-stage kidney disease. They
propose that the nodules represent smooth muscle proliferation
permitted by the life support of dialysis after vascular necrosis
(appeared in print after submission of this m.s. [51]).
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